Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 3Colonic Neoplasms 2Turcot syndrome 1

Interventions

Oxaliplatin 9Leucovorin 8Fluorouracil 8Bevacizumab 6Cetuximab 5Specimen Handling 4fludarabine 3Pemetrexed 3Nivolumab 3Magnetic Resonance Spectroscopy 3Cyclophosphamide 3pembrolizumab 2encorafenib 2dehydroftorafur 2aldesleukin 2Laparoscopy 2Irinotecan 2Immunoglobulin G 2Gemcitabine 2Folfox protocol 2Disulfides 2Conversion to Open Surgery 2Cisplatin 2Celecoxib 2Carboplatin 2ulixertinib 1trastuzumab biosimilar HLX02 1trametinib 1temsirolimus 1sapanisertib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Colonic Neoplasms × Celecoxib × 30 days × Clear all
NCT00159484 2026-05-28

Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer

University of Southern California

Phase 1/2 Completed
75 enrolled 25 charts
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT01150045 2026-05-19

Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery

Alliance for Clinical Trials in Oncology

Phase 3 Completed
2,527 enrolled 14 charts
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡